The change in p16 expression leads to gene downregulation and promotes the formation of epithelial cancers.30 In this study, seven treatment group samples expressed the p16 protein, while the other two did not, a phenomenon thought to indicate the heterogeneity of this type of cancer. Here, CDKN2A is linked to cancer.